NEW YORK, Jan 25 – Claiming victory in their DNA microarray patent disputes with Affymetrix, both Incyte and Hyseq said Thursday the US District Court for the Northern District of California narrowly interpreted Affymetrix’s patents to exclude their microarray manufacturing processes this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.